Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Newton

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Pharmacology, Biochemistry, and Behavior|January 18, 2006
A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegilineThomas F Newton, Richard De La Garza, Tim Fong, et al.
Pharmacogenetics and Genomics|July 6, 2016
The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individualsDaryl Shorter, David A Nielsen, Sara C Hamon, et al.
Psychiatry Research|August 5, 2015
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansThomas F Newton, Colin N Haile, James J Mahoney, et al.
Drug and Alcohol Dependence|June 15, 2014
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory studyChristopher D Verrico, Colin N Haile, James J Mahoney, et al.
The International Journal of Neuropsychopharmacology|January 8, 2014
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteersChristopher D Verrico, James J Mahoney, Daisy G Y Thompson-Lake, et al.
Psychiatric Genetics|June 8, 2017
Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genesMichelle A Patriquin, Sara C Hamon, Mark J Harding, et al.
The Psychological Record|October 4, 2017
A COMPARISON OF MAZUR'S <i>k</i> AND AREA UNDER THE CURVE FOR DESCRIBING STEEP DISCOUNTERSJin H Yoon, Richard De La Garza, Thomas F Newton, et al.
Pharmacology, Biochemistry, and Behavior|August 25, 2009
The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteersRichard De La Garza, Todd Zorick, Keith G Heinzerling, et al.
The Journal of Clinical Psychiatry|June 2, 2016
Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trialChristopher Rodgman, Christopher D Verrico, Manuela Holst, et al.
Psychopharmacology|September 16, 2005
Safety of intravenous methamphetamine administration during treatment with bupropionThomas F Newton, John D Roache, Richard De La Garza, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Pharmacology, Biochemistry, and Behavior|January 18, 2006
A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegilineThomas F Newton, Richard De La Garza, Tim Fong, et al.
Pharmacogenetics and Genomics|July 6, 2016
The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individualsDaryl Shorter, David A Nielsen, Sara C Hamon, et al.
Psychiatry Research|August 5, 2015
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansThomas F Newton, Colin N Haile, James J Mahoney, et al.
Drug and Alcohol Dependence|June 15, 2014
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory studyChristopher D Verrico, Colin N Haile, James J Mahoney, et al.
The International Journal of Neuropsychopharmacology|January 8, 2014
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteersChristopher D Verrico, James J Mahoney, Daisy G Y Thompson-Lake, et al.
Psychiatric Genetics|June 8, 2017
Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genesMichelle A Patriquin, Sara C Hamon, Mark J Harding, et al.
The Psychological Record|October 4, 2017
A COMPARISON OF MAZUR'S <i>k</i> AND AREA UNDER THE CURVE FOR DESCRIBING STEEP DISCOUNTERSJin H Yoon, Richard De La Garza, Thomas F Newton, et al.
Pharmacology, Biochemistry, and Behavior|August 25, 2009
The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteersRichard De La Garza, Todd Zorick, Keith G Heinzerling, et al.
The Journal of Clinical Psychiatry|June 2, 2016
Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trialChristopher Rodgman, Christopher D Verrico, Manuela Holst, et al.
Psychopharmacology|September 16, 2005
Safety of intravenous methamphetamine administration during treatment with bupropionThomas F Newton, John D Roache, Richard De La Garza, et al.
Pageof 8